Nexalin Technology, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 1.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Details
| Name | Nexalin Technology, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 8 |
| Founded | 2010 |
| Ipo Date | 2022-09-16 |
| Ceo | Mark White |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.15 |
| Isin | US65345B3006 |
| Cusip | 65345B300 |
| Cik | 1527352 |
| Sic | 3845 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Mark White | President, Chief Executive Officer and Director |
| Dr. David Owens M.D. | Chief Medical Officer, Member of Scientific Advisory Board and Director |
| John Patrick Claude | Co-Founder and Director of Engineering and Development |
| Justin Van Fleet CPA | Chief Financial Officer |
Contact
| Address | 1776 Yorktown, Suite 550, Houston, Texas 77056, United States |
| Phone | 832 260 0222 |
| Website | https://www.nexalin.com |